Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question: February

Staff  |  Issue: February 2014  |  February 1, 2014

Assessment:

  1. Rheumatoid arthritis: stable on chronic medicine
  2. Osteoporosis: stable on chronic medicine

Plan:

  1. The patient will start tumor necrosis factor inhibitor. The physician held a lengthy discussion with the patient concerning risks and benefits. A skin test and chest X-ray were performed for tuberculosis screen. Labs were drawn for disease evaluation and medication monitoring. The patient is to continue all other medicines.
  2. Osteoporosis: A dual-energy X-ray absorptio­metry scan was due and was ordered to reassess the patient’s osteoporosis. The patient is to continue Fosamax, calcium, and vitamin D.
  3. Labs were performed to check the toxicity level of the drugs. Complete blood count, comprehensive metabolic panel, erythrocyte sedimentation rate, C-reactive protein, and a hepatitis panel were ordered, due to the disease and medicines.

What level is the medical decision making for this E/M visit? Click here for the answer

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:Billing/CodingConditionsOsteoarthritis and Bone DisordersPractice SupportRheumatoid Arthritis Tagged with:BillingCodingEvaluation and ManagementimagingOsteoporosispatient careRheumatoid arthritisrheumatologist

Related Articles

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    Coding Corner Question

    December 1, 2010

    December’s Coding Challenge

    Coding Corner Question: November

    November 1, 2012

    Test your knowledge of the level of medical decision making (MDM) for an evaluation and management (E/M) office visit of a patient whose rheumatoid arthritis is worse on chronic medicine, whose osteoporosis is stable on chronic medicine, and who presents with a new problem of elevated blood pressure (BP)

    Prevent Osteoporotic Fractures with a Fracture Liaison Service

    May 18, 2019

    Imagine leaving the hospital after suffering a heart attack without being treated for hypertension or being started on a beta blocker. What would we think of the hospital where patients are never educated about the relationship between treating hypertension and reducing myocardial infarction and stroke risk? Unfortunately, this happens every day with osteoporosis and fractures…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences